STOCK TITAN
  1. Home
  2. News
  3. ALGN

Align Technology, Inc. - ALGN STOCK NEWS

Welcome to our dedicated news page for Align Technology (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Align Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Align Technology's position in the market.

News
Align Technology Receives US FDA 510(k) Clearance for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally
Rhea-AI Summary
Align Technology, a leading global medical device company (Nasdaq: ALGN), has announced that the U.S. Food and Drug Administration (FDA) has cleared Align’s Invisalign® Palatal Expander System for commercial availability in the U.S. The system is a modern and innovative direct 3D printed device based on proprietary and patented technology, providing a safe, comfortable, and clinically effective alternative to traditional palatal expanders. The Invisalign Palatal Expander System offers a full early intervention treatment solution for Phase 1 treatment, with broad patient applicability, including growing children, teens, and adults.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
clinical trial
-
News
Health Canada Issues Updated Medical Device License to Align Technology For the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion
Rhea-AI Summary
Align Technology, Inc. (Nasdaq: ALGN) has announced that Health Canada updated the medical device license for its Invisalign® Palatal Expander System, a modern and innovative direct 3D printed device based on proprietary and patented technology. The updated license is for broad patient applicability, including growing children, teens, and adults. The Invisalign Palatal Expander is Align’s first direct 3D printed orthodontic device and provides a safe, comfortable, and clinically effective alternative to traditional palatal expanders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.09%
Tags
none
-
News
Mojdeh Poul and Kevin Conroy Join Align Technology Board of Directors
Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) appointed Mojdeh Poul, former EVP and Group President of 3M Health Care, and Kevin Conroy, President, CEO, and Chairman of the Board of Exact Sciences, to its Board of Directors. Both bring extensive experience in the healthcare industry, with Mojdeh specializing in business strategy and transformation, while Kevin has a track record for growth and innovative solutions. Mojdeh and Kevin will be included in the company’s slate of director nominees in the proxy statement for Align’s 2024 Annual Meeting of Shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
management
News
Align Technology Opens 2024 Annual Research Program to Advance Orthodontic and Dental Patient Care
Rhea-AI Summary
Align Technology, Inc. has opened its 2024 Annual Research Award Program, offering up to $300,000 in funding for dental research initiatives. The program aims to advance patient care in orthodontics and dentistry. Align Technology has funded approximately $3 million in research since 2010.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none
-
News
Align Technology Announces $100 Million Open Market Repurchase
Rhea-AI Summary
Align Technology, Inc. plans to repurchase $100 million of its common stock through open market repurchases as part of its $1.0 billion stock repurchase program. The company's CEO, Joe Hogan, also intends to personally purchase $1.0 million of Align's common stock. The repurchases are expected to be completed by mid-December 2023 and will be funded with Align's cash on hand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
buyback
-
News
Align Technology to Speak at Upcoming Financial Conferences
Rhea-AI Summary
Align Technology, Inc. (Nasdaq: ALGN) has announced that it will be speaking at two upcoming financial conferences. The presentations will be webcast live and archived for three months. The first conference is the Piper Sandler 35th Annual Healthcare Conference on November 29, 2023, in New York, NY. The second conference is the 6th Annual Evercore ISI HealthCONx Conference on November 30, 2023, in Miami, FL.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.66%
Tags
conferences
News
Align Technology Announces $250 Million Accelerated Stock Repurchase Agreement
Rhea-AI Summary
Align Technology, Inc. has entered into a new accelerated stock repurchase agreement with Citibank, N.A. to repurchase $250 million of Align's common stock. The company's president and CEO, Joe Hogan, also intends to personally purchase $1.0 million of Align's common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
buyback
-
News
Align Technology Announces Third Quarter 2023 Financial Results
Rhea-AI Summary
Align Technology, Inc. (Nasdaq: ALGN) reported Q3'23 financial results. Clear aligner shipments to teenage patients increased 9.9% sequentially and 8.4% YoY. The company expects to repurchase up to $250.0 million of its common stock in Q4'23. Q3'23 total revenues were $960.2 million, up 7.8% YoY. Q3'23 diluted net income per share was $1.58, non-GAAP diluted net income per share was $2.14.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.88%
Tags
earnings
-
News
Align Technology to Announce Third Quarter 2023 Results on October 25, 2023
Rhea-AI Summary
Align Technology, Inc. will report Q3 2023 financial results on October 25, 2023. The results will be available on the Align website. A conference call will follow to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
earnings
News
Align Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit Where Leaders in Digital Orthodontics and Restorative Dentistry Share Best Practices for Leading Transformation in Dentistry
Rhea-AI Summary
Align Technology highlights recent innovations at the 2023 Invisalign GP Summit
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
none
Stock ALGN logo
Align Technology, Inc.

Nasdaq:ALGN

ALGN Rankings

#454 Ranked by Market Cap
#2094 Ranked by Stock Gains
N/A Ranked by Dividends

ALGN Stock Data

22.96B
69.96M
6.54%
88%
1.87%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
US
San Jose

About ALGN

align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi